Stellar Biotechnologies, Inc. Employment Agreements
14 Contracts & Agreements
- First Amendment to Amended and Restated Employment Agreement, by and between the Company and Pardeep Nijhawan, dated December 7, 2023 (Filed With SEC on December 15, 2023)
- Amended and Restated Employment Agreement, by and between the Company and Michael Brooks, dated August 4, 2023 (Filed With SEC on August 9, 2023)
- Amended and Restated Employment Agreement, by and between the Company and Pardeep Nijhawan, dated August 4, 2023 (Filed With SEC on August 9, 2023)
- Employment Agreement by and between the Company and Stephen Lemieux, dated June 26, 2023 (Filed With SEC on June 27, 2023)
- Amendment to Employment Agreement, entered into on April 12, 2022, by and between Michael Brooks and Edesa Biotech USA, Inc (Filed With SEC on May 13, 2022)
- Amendment to Employment Agreement, entered into on April 12, 2022, by and between Kathi Niffenegger and Edesa Biotech USA, Inc (Filed With SEC on May 13, 2022)
- Amendment to Employment Agreement, entered into on April 12, 2022, by and between Par Nijhawan and Edesa Biotech, Inc (Filed With SEC on May 13, 2022)
- Amendment to Employment Agreement, entered into on March 19, 2021, by and between Michael Brooks and Edesa Biotech, Inc (Filed With SEC on May 14, 2021)
- Amendment to Employment Agreement, entered into on March 19, 2021, by and between Kathi Niffenegger and Edesa Biotech USA, Inc (Filed With SEC on May 14, 2021)
- Amendment to Employment Agreement, entered into on March 19, 2021, by and between Par Nijhawan and Edesa Biotech, Inc (Filed With SEC on May 14, 2021)
- Employment Agreement by and between the Company and Kathi Niffenegger, dated December 1, 2020 (Filed With SEC on December 7, 2020)
- Employment Agreement, dated as of June 14, 2019, by and between the Registrant and Michael Brooks (Filed With SEC on June 20, 2019)
- Employment Agreement, dated as of June 14, 2019, by and between the Registrant and Dr. Pardeep Nijhawan (Filed With SEC on June 20, 2019)
- Employment Agreement, dated as of June 7, 2019, by and between the Company and Kathi Niffenegger (Filed With SEC on June 10, 2019)
